Keyphrases
Clinical Features
100%
Interleukin-1 Receptor-associated Kinase 4
87%
Stem Cell Mobilization
87%
Granulocyte Colony-stimulating Factor (G-CSF)
87%
Pediatric Patients
87%
Chemotherapy
87%
MyD88 Deficiency
87%
Ewing Sarcoma
87%
Plerixafor
87%
Clinical Outcomes
87%
Chromosome Fragility
87%
Prognostic Significance
87%
Mutation Type
87%
Fanconi Anemia
87%
Invasive Infection
70%
Invasive Pneumococcal Disease
52%
Biallelic mutations
37%
Stem Cell Collection
35%
Bacterial Infection
35%
Pseudomonas Aeruginosa (P. aeruginosa)
35%
Stem Cells
35%
Peripheral Blood
35%
Inflammation
35%
FANCG
25%
Bone Marrow Failure
25%
FANCA
25%
Novel Therapeutics
25%
Hypomorphism
25%
Apheresis
17%
High-dose Chemotherapy
17%
Stem Cell Support
17%
Myelosuppressive Chemotherapy
17%
Teenage Years
17%
Infectious Diseases
17%
Suspected Infection
17%
Autosomal Recessive
17%
Antibacterial Treatment
17%
Survivors
17%
Life-threatening Infections
17%
Life-threatening
17%
Malignant Tumor
17%
Aureus
17%
High Incidence
17%
Fungal Diseases
17%
Antipneumococcal
17%
Early childhood
17%
Myeloma
17%
Safe Agent
17%
Solid Tumors
17%
Impact on Patients
17%
Medicine and Dentistry
Stem Cell
87%
Pediatrics Patient
87%
Myeloid Differentiation Factor 88
87%
Clinical Feature
87%
Interleukin 1 Receptor Associated Kinase 4
87%
Stem Cell Mobilization
87%
Infection
87%
Plerixafor
87%
Granulocyte Colony Stimulating Factor
87%
Ewing Sarcoma
87%
Chemotherapy
87%
Pneumococcal Infection
32%
Bacterial Infection
21%
Pseudomonas aeruginosa
21%
Myeloma
17%
Solid Malignant Neoplasm
17%
Apheresis
17%
High Dose Chemotherapy
17%
Malignant Neoplasm
17%
Side Effect
17%
Salicylate Sodium
17%
Interleukin 1 Receptor
10%
Bacterial Disease
10%
Antibiotic Therapy
10%
Upper Respiratory Tract
10%
Consultation
10%
Toll Like Receptor 1
10%
Infancy
10%
Newborn Period
10%
Adolescence
10%
Infusion
10%
Staphylococcus Aureus
10%
Viral Disease
10%
Autosomal Recessive Inheritance
10%
Fungal Infection
10%
Parasitic Disease
10%
Antibiotic Prophylaxis
10%
Acute Chest Syndrome
9%
